Instrument Inactif

Communiqués Metabolix, Inc. Nasdaq

Actions

US5910188821

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

15/05	Yield10 Bioscience, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
15/05	Les plus fortes baisses de la mi-journée	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label	23/05	AQ
Yield10 Bioscience Announces First Quarter 2024 Financial Results	15/05	AQ
Yield10 Bioscience Announces Delisting from Nasdaq	15/05	AQ
Yield10 Bioscience Announces 1-for-24 Reverse Stock Split	01/05	AQ
Yield10 Bioscience : 2024 Special Meeting of Stockholders	02/04	PU
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results	01/04	AQ
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024	28/03	AQ
Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada	26/03	AQ
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States	21/03	AQ
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests	29/02	AQ
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock	14/02	AQ
Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program	07/02	AQ
Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil	08/01	AQ
USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States	15/11	AQ
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States	15/11	AQ
Yield10 Bioscience Announces Third Quarter 2023 Financial Results	14/11	AQ
Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023	08/11	AQ
Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land	31/10/23	AQ
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research	18/10/23	AQ
Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina	11/10/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Metabolix, Inc. Nasdaq

Actions

US5910188821

Communiqués

Filtres